Evidence map›Paper›PMID 38368461›Full record

ArticleNature communications2024

An alpha-helical lid guides the target DNA toward catalysis in CRISPR-Cas12a.

Aakash Saha, Mohd Ahsan, Pablo R Arantes, Michael Schmitz, Christelle Chanez, Martin Jinek, Giulia Palermo

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
12.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Article
  3. Architecture of a DNA-guided Cas12a.Nature structural & molecular biology · 2026
    Article
  4. Molecular mechanisms and biotechnology applications of CRISPR-Cas12a.Nature reviews. Molecular cell biology · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. A Cryptic Binding Pocket Regulates the Metal-Dependent Activity of Cas9.bioRxiv : the preprint server for biology · 2025
    Article
  18. Article
  19. Facilitating crRNA Design by Integrating DNA Interaction Features of CRISPR-Cas12a System.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Aakash SahaDepartment of Bioengineering, University of California Riverside, 900 University Avenue, Riverside, CA, 52512, USA.ORCID 0000-0003-0776-9771
Mohd Ahsan *Department of Bioengineering, University of California Riverside, 900 University Avenue, Riverside, CA, 52512, USA.ORCID 0000-0002-0583-4413
Pablo R Arantes *Department of Bioengineering, University of California Riverside, 900 University Avenue, Riverside, CA, 52512, USA.
Michael SchmitzDepartment of Biochemistry, University of Zürich, Winterthurerstrasse 190, CH-8057, Zürich, Switzerland.ORCID 0000-0003-3216-7350
Christelle ChanezDepartment of Biochemistry, University of Zürich, Winterthurerstrasse 190, CH-8057, Zürich, Switzerland.ORCID 0000-0002-3432-4375
Martin JinekDepartment of Biochemistry, University of Zürich, Winterthurerstrasse 190, CH-8057, Zürich, Switzerland.ORCID 0000-0002-7601-210X
Giulia PalermoDepartment of Bioengineering, University of California Riverside, 900 University Avenue, Riverside, CA, 52512, USA. giulia.palermo@ucr.edu.ORCID 0000-0003-1404-8737
University of California, Riverside · USUniversity of Zurich · CH

Funding

Breakthrough Molecular Dynamics Research via an Anton2 SupercomputerR01GM116961 · NIGMS · CARNEGIE-MELLON UNIVERSITY · PI BLOOD, PHILIP D. · 2016 to 2023
$3.0M
Investigating the metal-dependent function, allostery and inhibition of CRISPR-Cas9R01GM141329 · NIGMS · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI PALERMO, GIULIA · 2021 to 2025
$1.7M
Howard Hughes Medical InstituteNIGMS NIH HHS R01 GM116961NIGMS NIH HHS R01 GM141329
6 · The paper itself

Abstract

CRISPR-Cas12a is a powerful RNA-guided genome-editing system that generates double-strand DNA breaks using its single RuvC nuclease domain by a sequential mechanism in which initial cleavage of the non-target strand is followed by target strand cleavage. How the spatially distant DNA target strand traverses toward the RuvC catalytic core is presently not understood. Here, continuous tens of microsecond-long molecular dynamics and free-energy simulations reveal that an α-helical lid, located within the RuvC domain, plays a pivotal role in the traversal of the DNA target strand by anchoring the crRNA:target strand duplex and guiding the target strand toward the RuvC core, as also corroborated by DNA cleavage experiments. In this mechanism, the REC2 domain pushes the crRNA:target strand duplex toward the core of the enzyme, while the Nuc domain aids the bending and accommodation of the target strand within the RuvC core by bending inward. Understanding of this critical process underlying Cas12a activity will enrich fundamental knowledge and facilitate further engineering strategies for genome editing.

Indexed as

CRISPR-Cas SystemsRNA, Guide, CRISPR-Cas SystemsCatalysisDNAGene EditingDNARNA, Guide, CRISPR-Cas Systems

Identifiers

PMID38368461
PMCPMC10874386
OpenAlexW4391896781

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.